780:, meaning it can transfer K ions across biological membranes. Typically, the mitochondrial inner membrane is not permeable to K and maintains a set electrochemical gradient. In excitable cells, mitochondria can contain a K channel that, when opened, can cause mitochondrial stress by inducing mitochondrial swelling, changing the electrochemical gradient, and stimulating respiration. Bafilomycin A1 treatment can induce mitochondrial swelling in the presence of K ions, stimulate the oxidation of pyrimidine nucleotides and uncouple
194:
921:(IBM) is relatively common in patients over 50 years of age and involves over activation of autophagic flux. In this condition, increased autophagy results in an increase in protein degradation and therefore an increase in the presentation of antigenic peptides in muscles. This can cause over-activation of immune cells. Treatment with bafilomycin can prevent the acidification of lysosomes and therefore autophagy, decreasing the number of antigenic peptides digested and displayed to the immune system.
439:
700:. Autophagosomes then fuse with lysosomes facilitating the degradation of engulfed cargo by lysosomal proteases. This process is critical in maintaining the cell's store of amino acids and other nutrients during times of nutrient deprivation or other metabolic stresses. Bafilomycin interferes with this process by inhibiting the acidification of the lysosome through its interaction with V-ATPase. Lack of lysosomal acidification prevents the activity of lysosomal proteases like
597:(a3) and renal intercalated cells (a4). If located at the lysosomal membrane, this results in the acidification of the lysosome as lumenal pH is lowered, enabling activity of lysosomal hydrolases. When V-ATPase is located at the plasma membrane, proton extrusion through the pump causes the acidification of the extracellular space, which is utilized by specialized cells such as osteoclasts, epididymal clear cells, and renal epithelial intercalated cells.
708:
467:(ATP) hydrolysis to pump protons across a biological membrane. When bafilomycin and other inhibitors of V-ATPase, such as concanamycin, were first discovered in the 1980s they were used to establish the presence of V-ATPase in specialized cells types and tissues, characterizing the proton pump's distribution. Structurally, V-ATPase consists of 13 distinct subunits that together make up the membrane spanning V
1018:, displayed an increased effect when administered after bafilomycin treatment. With bafilomycin, faster contraction and relaxation of the aorta was seen as bafilomycin prevented the ion trapping of xylometazoline in the lysosome. Without pre-treatment with bafilomycin, the functional V-ATPase causes the lysosome to become a reservoir for xylometazoline, slowing its effect on contractility.
37:
989:
452:
284:
949:
autophagy is stimulated, bafilomycin blocks its final stage of autophagosome-lysosomal fusion resulting in the accumulation of autophagosomes. Levels of autophagy related proteins associated with autophagosomes, such as LC3, can then be monitored to determine the level of autophagosome formation induced by nutrient deprivation.
973:, are known as lysosomotropic drugs. These drugs are weak bases that become protonated in the acidic environment of the lysosome. This traps the otherwise non-protonated compound within the lysosome, as protonation prevents its passage back across the lipid membrane of the organelle. This phenomenon is known as
948:
Bafilomycin is commonly used to study this autophagic flux in neurons, among other cell types. To do this, neurons are first put into nutrient rich conditions then into nutrient starved conditions to stimulate autophagy. Bafilomycin is co-administered in the condition of nutrient stress so that while
888:
exports a membrane network into the red blood cell cytoplasm and also inserts several of its own proteins into the host membrane, including its own V-ATPase. This proton pump has a role in maintaining the intracellular pH of the infected red blood cell and facilitating the uptake of small metabolites
634:
With its role in lysosomal acidification, V-ATPase is also crucial in driving the transport of ions and small molecules into the cytoplasm, particularly calcium and amino acids. Additionally, its acidification of endosomes is critical in receptor endocytosis as low pH tends to drive ligand release as
2388:
Pérez-Vargas J, Shapira T, Olmstead AD, Villanueva I, Thompson CA, Ennis S, Gao G, De Guzman J, Williams DE, Wang M, Chin A, Bautista-Sánchez D, Agafitei O, Levett P, Xie X, Nuzzo G, Freire VF, Quintana-Bulla JI, Bernardi DI, Gubiani JR, Suthiphasilp V, Raksat A, Meesakul P, Polbuppha I, Cheenpracha
944:
typically display elevated levels of protein aggregates within the cell that contribute to dysfunction of neurons and eventual neuronal death. As a method of protein degradation within the cell, autophagy can traffic these protein aggregates to be degraded in the lysosome. Although it is unclear the
831:
V-ATPase dysregulation is thought to play a role in resistance to cancer therapies, as aberrant acidification of the extracellular environment can protonate chemotherapeutics, preventing their entry into the cell. It is unclear if` V-ATPase dysregulation is a direct cause of associated poor clinical
732:
following a 12-24 hour treatment with 100 or 400 nM Bafilomycin. However, further studies have failed to see this inhibition of fusion with similar bafilomycin treatments. These contradictory results have been explained by time differences among treatments as well as use of different cell lines. The
560:
c subunit. These data suggested that the bafilomycin binding site was on the outer surface of the Vo domain, at the interface between two c subunits. This binding site has recently been described in high resolution by two groups that used cryo electron microscopy to obtain structures of the V-ATPase
555:
domain. It was further found that amino acid changes within subunit a could also lower V-ATPase-Bafilomycin interaction, indicating a minor role of subunit a in bafilomycin binding in addition to subunit c. An analysis of nine mutations that conferred resistance to bafilomycin showed all of them to
1026:
As a lysosomotropic drug, chloroquine typically accumulates in the lysosome disrupting their degradative function, inhibiting autophagy, and inducing apoptosis through Bax-dependent mechanisms. However, in cultured cerebellar granule neurons (CGNs) low treatment with
Bafillomycin of 1 nM decreased
813:
and increased expression of HIF1alpha. These effects suggest that inhibition of V-ATPase with bafilomycin can induce a cellular stress response, including autophagy and eventual apoptosis. These somewhat contradictory effects of V-ATPase inhibition in terms of inhibition or induction of apoptosis
593:. In mammals, location of the V-ATPase can be linked to the specific isoform of subunit a that the complex has. Isoforms a1 and a2 target V-ATPase intracellularly, to synaptic vesicles and endosomes respectively. Subunits a3 and a4, however, mediate V-ATPase localization to the plasma membrane in
647:
When at the plasma membrane, V-ATPase function is critical in the acidification of the extracellular environment, which is seen with osteoclasts and epididymal clear cells. When present at the plasma membrane in renal epithelial intercalated cells, V-ATPase is important for acid secretion, which
997:
When one of these drugs is co-applied to cells with bafilomycin A1, the action of bafilomycin A1 prevents the acidification of the lysosome, therefore preventing the phenomenon of ion trapping in this compartment. As the lysosome cannot acidify, lysosomotropic drugs do not become protonated and
928:
patients, the autophagy pathway has been found to be altered in both B and T cells. Particularly, more autophagic vacuoles were seen in T cells as well as increased LC3-11 staining for autophagosomes, indicating increased autophagy. Increased autophagy can also be seen in naïve patient B cell
546:
subunit a could restore function. This suggested bafilomycin interacted specifically with subunit a of V-ATPase; however, another study contradicted this finding. A group found that by using a bafilomycin affinity chromatography column V-ATPase could be purified, and that addition of DCCD, an
568:
c subunit of the V-ATPase complex and inhibits proton translocation. Although the interaction between bafilomycin and V-ATPase is not covalent, its low dissociation constant of about 10 nM describes the strength of its interaction and can make the effects of bafilomycin difficult to reverse.
511:
domain of the enzyme, enabling both the rotation of the central stalk of the pump, made up of subunits D, F and d, and the rotation of the proteolipid ring. This rotation puts the protonated glutamic acid residues in contact with a luminal hemichannel located in subunit a. Within subunit a,
723:
In addition to blocking the acidification of the lysosome, Bafilomycin has been reported to block the fusion of autophagosomes with lysosomes. This was initially found in a paper by
Yamamoto, et al. in which the authors used bafilomycin A1 to treat rat hepatoma H-4-II-E cells. By
992:
Diagram showing how protonation of weak bases like chloroquine in the acidic environment of the lysosome results in ion trapping, or accumulation of the weak base in the lysosome. Bafilomycin inhibits this trapping through its action on V-ATPase, which normally acidifies the
719:
Since V-ATPase is widely distributed within the cell, Bafilomycin is only specific as an autophagy inhibitor for a short amount of time. Other effects are seen outside this short window, including interference in the trafficking of endosomes and proteasomal inhibition.
1027:
chloroquine induced apoptosis without affecting chloroquine inhibition of autophagy. The exact mechanism of this protection is unknown, although it is hypothesized to lie downstream of autophagosome-lysosome fusion yet upstream of Bax induction of apoptosis.
2389:
S, Jaidee W, Kanokmedhakul K, Yenjai C, Chaiyosang B, Teles HL, Manzo E, Fontana A, Leduc R, Boudreault PL, Berlinck RG, Laphookhieo S, Kanokmedhakul S, Tietjen I, Cherkasov A, Krajden M, Nabi IR, Niikura M, Shi PY, Andersen RJ, Jean F (January 2023).
728:, they saw a blockage of autophagosome-lysosome fusion after using bafilomycin at a concentration of 100 nM for 1 hour. This has been confirmed by other studies, particularly two that found decreased colocalization of mitochondria and lysosomes by
808:
The mechanism by which bafilomycin causes this cancer specific anti-proliferative effect is multifactorial. In addition to the induction of caspase-dependent apoptosis through the mitochondrial pathway, bafilomycin also causes increased levels of
784:. Ascending concentrations of bafilomycin were found to linearly increase the amount of K that traversed the mitochondrial membrane, confirming it acts as an ionophore. Compared to other ionophores, however, bafilomycin has a low affinity for K.
668:, and renal acidosis. Additionally, V-ATPase can be found at the plasma membrane of some invasive cancer cells including breast, prostate and liver cancer, among others. In human lung cancer samples, V-ATPase expression was correlated with
525:
For more than ten years after bafilomycin was discovered as a V-ATPase inhibitor, the site of its interaction with V-ATPase was unclear. Beginning studies used the chromaffin granule V-ATPase to suggest that bafilomycin interacted with the
1047:
resistant cells, V-ATPase expression was found to be increased, and co-treatment of bafilomycin with cisplatin sensitized these cells to cisplatin-induced cytotoxicity. Bafilomycin has also been shown to increase the efficacy of
430:
As one of the first identified and most commonly used, bafilomycin A1 is of particular importance, especially as its structure serves as the core of all other bafilomycins. With its large structure, bafilomycin has multiple
3308:
2780:
1005:
Pretreating cells with bafilomycin before administration of a cationic drug can alter the kinetics of the cationic compound. In a rabbit contractility assay, bafilomycin was used to pre-treat isolated rabbit
2083:
Marceau F, Bawolak MT, Lodge R, Bouthillier J, Gagné-Henley A, Gaudreault RC, Morissette G (February 2012). "Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs".
740:, an increase in the autophagosome marker LC3-II has been seen with Bafilomycin treatment. This occurs as autophagosomes fail to fuse with lysosomes, which normally stimulates the degradation of LC3-II.
648:
contributes to the acidification of urine. In response to reduced plasma pH, increased levels of V-ATPase are typically trafficked to the plasma membrane in these cells by phosphorylation of the pump by
516:
residues serve to stabilize the deprotonated form of glutamic acid and allow the release of their protons. This rotation and proton transfer brings the protons through the pump and across the membrane.
805:
bafilomycin's anti-proliferative effect appears to be specific to cancer cells over normal cells, which is seen with selective inhibition of hepatoblastoma cell growth compared to healthy hepatocytes.
3301:
945:
exact role continuous autophagy, or autophagic flux, plays in neuronal homeostasis and disease states, it has been shown that autophagic dysfunction can be seen in neurodegenerative diseases.
801:
and reduced clinical outcome. Bafilomycin application has been shown to reduce cell growth in various cancer cell lines across multiple cancer types by induction of apoptosis. Additionally,
1387:
Saris NE, Andersson MA, Mikkola R, Andersson LC, Teplova VV, Grigoriev PA, Salkinoja-Salonen MS (August 2009). "Microbial toxin's effect on mitochondrial survival by increasing K+ uptake".
889:
at equilibrium. Treatment of the parasitized red blood cell with bafilomycin prevents the extracellular acidification, causing a dip in intracellular pH around the malarial parasite.
3294:
3274:
2773:
297:
3967:
3971:
3963:
2766:
1207:"Vacuolar H(+)-ATPase localized in plasma membranes of malaria parasite cells, Plasmodium falciparum, is involved in regional acidification of parasitized erythrocytes"
797:
In many cancers, it has been found that various subunits of V-ATPase are upregulated. Upregulation of these subunits appears to be correlated with increased tumor cell
828:, bafilomycin also caused tumor regression in MDA-MB-231 xenograft mice. In a HepG2 orthotropic HCC xenograft model in nude mice, bafilomycin prevented tumor growth.
408:
and shown to have antibiotic activity against some yeast, Gram-positive bacteria and fungi. Bafilomycin A1 was also shown to have an anti-proliferative effect on
3390:
3385:
334:, including anti-tumor, anti-parasitic, immunosuppressant and anti-fungal activity. The most used bafilomycin is bafilomycin A1, a potent inhibitor of cellular
3263:
2937:
2269:
Lumkwana D, du Toit A, Kinnear C, Loos B (June 2017). "Autophagic flux control in neurodegeneration: Progress and precision targeting-Where do we stand?".
764:, which is an initiator of apoptosis. Bafilomycin has also been shown to induce both inhibition of autophagy and subsequent induction of apoptosis in
551:
c subunit, drastically decreased bafilomycin's affinity for V-ATPase. This suggested that bafilomycin interacted more strongly with subunit c of the V
852:(ABC) transporters. These transporters are identified as good anti-fungal targets as they render organisms unable to cope with cation stress. When
814:
demonstrate that bafilomycin's function is critically dependent on cellular context, and can mediate either a pro-survival or pro-death phenotype.
435:
and functional groups, which makes modifying its structure difficult, a task that has been attempted to reduce the compound's associated toxicity.
684:
As the target of
Bafilomycin V-ATPase, is involved in many aspects of cellular function, Bafilomycin treatment greatly alters cellular processes.
419:. In 2010, 9-hydroxy-bafilomycin D, 29-hydroxy-bafilomycin D and a number of other bafilomycins were identified from the endophytic microorganism
3683:
353:(V-ATPase) enzyme, a membrane-spanning proton pump that acidifies either the extracellular environment or intracellular organelles such as the
3637:
3523:
3448:
3420:
3080:
3344:
998:
subsequently trapped in the lysosome in the presence of bafilomycin. Additionally, when cells are preloaded with lysosomotropic drugs
3642:
3528:
2142:
Vinod V, Padmakrishnan CJ, Vijayan B, Gopala S (April 2014). "'How can I halt thee?' The puzzles involved in autophagic inhibition".
3256:
2052:
1356:
3367:
3617:
3501:
849:
3739:
3436:
605:
As it promotes the acidification of lysosomes, endosomes, and secretory vesicles, V-ATPase contributes to processes including:
977:. Trapping of the cationic compound also draws water into the lysosome through an osmotic effect, which can sometimes lead to
1812:"The bafilomycin/concanamycin binding site in subunit c of the V-ATPases from Neurospora crassa and Saccharomyces cerevisiae"
2646:
Muller S, Brun S, René F, de Sèze J, Loeffler JP, Jeltsch-David H (August 2017). "Autophagy in neuroinflammatory diseases".
635:
well as receptor cleavage which contributes to signaling events, such as through the release of the intracellular domain of
542:
domain to the coated vesicles. Further narrowing bafilomycin's interaction site, they found that specific addition of just V
89:)-16- -2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one
1002:, then treated with bafilomycin, bafilomycin acts to release the cationic compound from its accumulation in the lysosome.
577:
V-ATPase is ubiquitous in mammalian cells and plays an important role in many cellular processes. It is localized to the
304:
4026:
3959:
3836:
3335:
3249:
2812:
1861:"A model for the proteolipid ring and bafilomycin/concanamycin-binding site in the vacuolar ATPase of Neurospora crassa"
925:
660:
Clinically, dysfunction of V-ATPase has been correlated with several diseases in humans. Some of these diseases include
4001:
3583:
2758:
2684:
Kuzu OF, Toprak M, Noory MA, Robertson GP (March 2017). "Effect of lysosomotropic molecules on cellular homeostasis".
2177:
Duffy A, Le J, Sausville E, Emadi A (March 2015). "Autophagy modulation: a target for cancer treatment development".
832:
outcome or if its dysregulation primarily effects the response to treatment. Although treatment with bafilomycin and
357:
of animal cells or the vacuole of plants and fungi. At higher micromolar concentrations, bafilomycin A1 also acts on
3463:
463:
Within the cell, bafilomycin A1 specifically interacts with the proton pump V-ATPase. This large protein depends on
4016:
4006:
3831:
3716:
3706:
1551:
Li Z, Du L, Zhang W, Zhang X, Jiang Y, Liu K, Men P, Xu H, Fortman JL, Sherman DH, Yu B, Gao S, Li S (April 2017).
941:
330:. Their chemical structure is defined by a 16-membered lactone ring scaffold. Bafilomycins exhibit a wide range of
2546:
Icho S, Rujas E, Muthuraman K, Tam J, Liang H, Landreth S, Liao M, Falzarano D, Julien JP, Melnyk RA (July 2022).
3478:
3144:
2548:"Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells"
824:
mouse models by 50% and did not show toxic effects at a dosing of 1 mg/kg. Additionally, when combined with
781:
382:
in 1983. During a screen seeking to identify microbial secondary metabolites whose activity mimicked that of two
2922:
1089:
Dröse S, Altendorf K (January 1997). "Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases".
3922:
3763:
3096:
3042:
1040:
1015:
757:
531:
3744:
3729:
3514:
3909:
3803:
3101:
3026:
2857:
2727:
Ravanan P, Srikumar IF, Talwar P (November 2017). "Autophagy: The spotlight for cellular stress responses".
2491:"In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs"
1440:"Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells"
918:
854:
810:
729:
636:
397:
672:. A large number of V-ATPase subunit mutations have also been identified in a number of cancers, including
189:
3894:
3856:
3533:
3400:
3116:
2789:
504:
464:
392:
3563:
3428:
2963:
2837:
131:
3776:
3753:
3327:
3324:
2804:
2438:
Zhang C, Wei B, Liu Z, Yao W, Li Y, Lu J, Ge C, Yu X, Li D, Zhu Y, Shang C, Jin N, Li X (January 2023).
1499:"Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases"
876:
733:
effect of
Bafilomycin on autophagosome-lysosome fusion is complex and time dependent in each cell line.
696:
is the process by which the cell degrades its own organelles and some proteins through the formation of
321:
49:
3793:
3553:
3991:
3871:
3627:
3174:
3106:
2502:
2093:
1921:
1451:
1396:
378:
3578:
438:
4021:
3927:
3861:
3816:
3734:
3412:
3111:
3047:
821:
725:
673:
620:
331:
101:
3538:
1975:"Cryo-EM of the Yeast VO Complex Reveals Distinct Binding Sites for Macrolide V-ATPase Inhibitors"
1155:"Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer"
3884:
3375:
2897:
2709:
2294:
2202:
2010:
1420:
582:
3889:
3622:
3558:
3286:
858:
was treated with bafilomycin, growth inhibition was observed. Bafilomycin has also been used in
2917:
1611:"Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection"
368:
research applications; however, its clinical use is limited by a substantial toxicity profile.
4011:
3486:
3468:
3169:
2744:
2701:
2663:
2628:
2577:
2528:
2471:
2420:
2370:
2335:
2286:
2246:
2194:
2159:
2119:
2058:
2048:
2002:
1994:
1955:
1937:
1890:
1882:
1841:
1833:
1792:
1732:
1684:
1632:
1584:
1526:
1518:
1479:
1412:
1362:
1352:
1324:
1272:
1228:
1184:
1106:
756:, or programmed cell death. Additionally, in some cell lines it has been found to disrupt the
455:
Depiction of the molecular subunits that make up V-ATPase, the main target of
Bafilomycin A1.
383:
151:
3996:
3899:
3841:
3701:
3660:
3592:
3159:
2968:
2821:
2801:
2736:
2693:
2655:
2618:
2608:
2567:
2559:
2518:
2510:
2461:
2451:
2410:
2402:
2362:
2325:
2278:
2236:
2186:
2151:
2109:
2101:
2040:
1986:
1945:
1929:
1872:
1823:
1782:
1774:
1722:
1674:
1666:
1622:
1574:
1564:
1510:
1469:
1459:
1404:
1314:
1306:
1262:
1218:
1174:
1166:
1098:
661:
649:
232:
3696:
111:
4031:
3846:
3543:
3149:
1049:
669:
590:
578:
491:
In order to move protons across the membrane, a proton first enters subunit a within the V
848:
Bafilomycins have been shown to inhibit plasma membrane ATPase (P-ATPase) as well as the
193:
2506:
2353:
Weber SM, Levitz SM, Harrison TS (August 2000). "Chloroquine and the fungal phagosome".
2097:
1925:
1455:
1400:
1043:(MMP) levels by depressing Bcl-xL's mitochondrial protective role. Additionally, within
3932:
3607:
3548:
3052:
2993:
2983:
2958:
2892:
2623:
2596:
2572:
2547:
2523:
2490:
2466:
2439:
2415:
2390:
1950:
1909:
1787:
1762:
1679:
1654:
1653:
Yu Z, Zhao LX, Jiang CL, Duan Y, Wong L, Carver KC, Schuler LA, Shen B (January 2011).
1579:
1552:
1319:
1294:
1179:
1154:
1011:
881:
749:
628:
432:
409:
396:, ticks, and tapeworms, in addition to stimulating the release of γ-aminobutyruc acid (
275:
2366:
2044:
1474:
1439:
1349:
Antimicrobial drug resistance handbook. Volume 2, Clinical and epidemiological aspects
707:
412:-stimulated T cells. However, its high toxicity has prevented use in clinical trials.
3985:
3940:
3851:
3785:
3602:
3568:
3453:
3380:
3362:
3199:
3179:
3131:
3070:
3060:
2882:
2713:
2489:
Elmorsy MA, El-Baz AM, Mohamed NH, Almeer R, Abdel-Daim MM, Yahya G (February 2022).
2014:
1251:"A malaria parasite-encoded vacuolar H(+)-ATPase is targeted to the host erythrocyte"
978:
697:
665:
496:
358:
343:
326:
182:
2440:"Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model"
2406:
2314:"Bafilomycin A1 inhibits autophagy and induces apoptosis in MG63 osteosarcoma cells"
2282:
2206:
1424:
215:
3164:
2862:
2298:
974:
765:
761:
712:
2953:
2842:
1205:
Hayashi M, Yamada H, Mitamura T, Horii T, Yamamoto A, Moriyama Y (November 2000).
1068:
2659:
530:
domain. Two further studies confirmed this hypothesis using V-ATPase from bovine
3826:
3655:
3650:
3632:
3491:
3395:
3357:
3228:
3220:
2998:
966:
930:
863:
837:
615:
401:
2697:
2514:
2456:
2391:"Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics"
2155:
2105:
1990:
1933:
1778:
1763:"Recent Insights into the Structure, Regulation, and Function of the V-ATPases"
1655:"Bafilomycins produced by an endophytic actinomycete Streptomyces sp. YIM56209"
1497:
Dröse S, Bindseil KU, Bowman EJ, Siebers A, Zeeck A, Altendorf K (1993-04-20).
1444:
Proceedings of the
National Academy of Sciences of the United States of America
3597:
3320:
3189:
3184:
3153:
3139:
3121:
3003:
2912:
2872:
2847:
2797:
2740:
2190:
2114:
970:
906:
898:
798:
594:
255:
142:
17:
1998:
1941:
1886:
1837:
1522:
1408:
1366:
534:. They showed that application of bafilomycin inhibited proton flow through V
3821:
3612:
3317:
3126:
2988:
2927:
1569:
1464:
1072:
1044:
833:
825:
777:
753:
701:
693:
339:
335:
36:
2748:
2705:
2667:
2632:
2595:
Sabino C, Basic M, Bender D, Elgner F, Himmelsbach K, Hildt E (June 2019).
2581:
2532:
2475:
2424:
2374:
2339:
2290:
2250:
2198:
2163:
2123:
2062:
2006:
1974:
1959:
1894:
1877:
1860:
1845:
1828:
1811:
1796:
1736:
1688:
1636:
1588:
1416:
1328:
1276:
1267:
1250:
1232:
1223:
1206:
1188:
581:
and the cellular organelles that are derived from it, including lysosomes,
2330:
2313:
1530:
1498:
1483:
1110:
988:
3473:
3458:
2907:
2887:
2877:
2563:
902:
897:
Bafilomycin A1 and bafilomycin D have shown antiviral properties against
586:
513:
404:. Independently, bafilomycin A1 and other derivatives were isolated from
354:
350:
162:
2225:"Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?"
1670:
1514:
1102:
905:. Bafilomycin A1 has also demonstrated antiviral properties against the
171:
2978:
2867:
1973:
Keon KA, Benlekbir S, Kirsch SH, Müller R, Rubinstein JL (2022-03-18).
1727:
1710:
1295:"Immune and myodegenerative pathomechanisms in inclusion body myositis"
451:
423:
YIM56209. From 2004 to 2011, bafilomycins F-K were isolated from other
342:, transporting potassium K+ across biological membranes and leading to
202:
2613:
2241:
2224:
1627:
1610:
1170:
479:
domain in the cytosol is made up of subunits A through H whereas the V
3674:
3017:
2902:
2852:
1310:
1249:
Marchesini N, Vieira M, Luo S, Moreno SN, Docampo R (November 2005).
737:
122:
692:
Bafilomycin A1 is most known for its use as an autophagy inhibitor.
386:, bafilomycin C1 was identified as an inhibitor of P-ATPase with a k
274:
Except where otherwise noted, data are given for materials in their
2938:
1036:
1007:
706:
450:
437:
2223:
Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC (October 2008).
929:
subsets. Bafilomycin A1 treatment lowered the differentiation of
820:
bafilomycin reduced average tumor volume in MCF-7 and MDA-MB-231
3573:
2973:
495:
domain through a cytoplasmic hemichannel. This allows conserved
3290:
2762:
538:
and that this inhibition could be overcome by adding back the V
3684:
2597:"Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection"
866:
inhibitor FK506, displaying synergistic anti-fungal activity.
415:
Two years later, bafilomycins D and E were also isolated from
1908:
Wang R, Wang J, Hassan A, Lee CH, Xie XS, Li X (2021-03-19).
937:
Clearance of protein aggregates in neurodegenerative diseases
564:
Overall, bafilomycin binds with nanomolar efficiency to the V
2031:
Weisz OA (2003-01-01). "Acidification and protein traffic".
390:
of 11 μM. Bafilomycin C1 was found to have activity against
364:
Bafilomycin A1 serves as an important tool compound in many
3345:
2495:
Environmental
Science and Pollution Research International
1910:"Molecular basis of V-ATPase inhibition by bafilomycin A1"
1859:
Bowman BJ, McCall ME, Baertsch R, Bowman EJ (2006-10-20).
1810:
Bowman EJ, Graham LA, Stevens TH, Bowman BJ (2004-08-06).
1761:
Cotter K, Stransky L, McGuire C, Forgac M (October 2015).
1153:
Whitton B, Okamoto H, Packham G, Crabb SJ (August 2018).
3502:
3081:
2312:
Xie Z, Xie Y, Xu Y, Zhou H, Xu W, Dong Q (August 2014).
1035:
Bafilomycin has been shown to potentiate the effect of
292:
442:
880:, the causative agent of malaria. Upon infection of
3908:
3870:
3802:
3762:
3715:
3682:
3673:
3500:
3343:
3334:
3219:
3212:
3079:
3025:
3016:
2943:
Tooltip
Vesicular inhibitory amino acid transporter
2936:
2820:
2811:
1438:Bowman EJ, Siebers A, Altendorf K (November 1988).
459:: NOchotny at the English language Knowledge (XXG).
376:Bafilomycin A1, B1 and C1 were first isolated from
3717:
704:so that engulfed cargo can no longer be degraded.
483:domain is made up of subunits a, d, e, c, and c".
361:, which have a phosphorylated transitional state.
1244:
1242:
715:and the points of intervention of bafilomycin A1.
3764:
2264:
2262:
2260:
2218:
2216:
874:Bafilomycin has been shown to be active against
214:
3910:
3804:
3027:
2078:
2076:
2074:
2072:
1293:Keller CW, Schmidt J, Lünemann JD (June 2017).
1148:
1146:
1144:
1142:
1140:
110:
3689:Tooltip Glutamine aminohydrolase (glutaminase)
1756:
1754:
1752:
1750:
1748:
1746:
1711:"Inhibitors of V-ATPases: old and new players"
1604:
1602:
1600:
1598:
1299:Annals of Clinical and Translational Neurology
1200:
1198:
1138:
1136:
1134:
1132:
1130:
1128:
1126:
1124:
1122:
1120:
760:of the mitochondria and induce the release of
338:. Bafilomycins have also been found to act as
3302:
2774:
2137:
2135:
2133:
2026:
2024:
1342:
1340:
1338:
1288:
1286:
8:
3872:
2679:
2677:
1704:
1702:
1700:
1698:
1382:
1380:
1378:
1376:
1084:
1082:
1080:
2790:
711:Schematic representing the formation of an
3968:Metabotropic glutamate receptor modulators
3679:
3350:Tooltip Excitatory amino acid transporters
3340:
3309:
3295:
3287:
3216:
3022:
2817:
2781:
2767:
2759:
1648:
1646:
1546:
1544:
1542:
1540:
768:cells as well as other cancer cell lines.
192:
150:
28:
3275:Glutamate metabolism/transport modulators
2622:
2612:
2571:
2522:
2465:
2455:
2414:
2329:
2240:
2113:
1949:
1876:
1827:
1786:
1726:
1678:
1626:
1578:
1568:
1473:
1463:
1318:
1266:
1222:
1178:
499:residues within the proteolipid ring of V
3972:GABA metabolism and transport modulators
3964:Ionotropic glutamate receptor modulators
3507:Tooltip Vesicular glutamate transporters
3175:Valproate semisodium (divalproex sodium)
3086:Tooltip γ-Aminobutyrate aminotransferase
2822:
987:
589:. V-ATPase can also be found within the
503:subunits c and c" to become protonated.
349:Bafilomycin A1 specifically targets the
1061:
170:
1609:Shacka JJ, Klocke BJ, Roth KA (2006).
183:
3544:Amido black 10B (naphthol blue black)
2552:Antimicrobial Agents and Chemotherapy
1709:Huss M, Wieczorek H (February 2009).
130:
7:
2179:Cancer Chemotherapy and Pharmacology
840:effect on cancer cell cytotoxicity.
2863:Deramciclane (EGIS-3886, EGYT-3886)
2086:Toxicology and Applied Pharmacology
1865:The Journal of Biological Chemistry
1816:The Journal of Biological Chemistry
1715:The Journal of Experimental Biology
1557:The Journal of Biological Chemistry
1255:The Journal of Biological Chemistry
1211:The Journal of Biological Chemistry
1091:The Journal of Experimental Biology
205:
3722:Tooltip Aspartate aminotransferase
752:, bafilomycin was found to induce
573:V-ATPase localization and function
25:
507:(ATP) is then hydrolyzed by the V
3769:Tooltip Alanine aminotransferase
2033:International Review of Cytology
1389:Toxicology and Industrial Health
521:Bafilomycin–V-ATPase interaction
282:
35:
3915:Tooltip Glutamate decarboxylase
3809:Tooltip Glutamate dehydrogenase
3032:Tooltip Glutamate decarboxylase
2407:10.1016/j.antiviral.2022.105484
2355:Current Opinion in Microbiology
2283:10.1016/j.pneurobio.2017.03.006
278:(at 25 °C , 100 kPa).
3900:Phosphinothricin (glufosinate)
1767:Trends in Biochemical Sciences
933:and decreased their survival.
1:
3960:Receptor/signaling modulators
3250:Receptor/signaling modulators
2367:10.1016/S1369-5274(00)00102-8
2045:10.1016/S0074-7696(03)01005-2
1052:in anti-cancer applications.
965:Some cationic drugs, such as
609:vesicular/protein trafficking
3877:Tooltip Glutamine synthetase
3268:receptor positive modulators
2660:10.1016/j.autrev.2017.05.015
1016:alpha-adrenoreceptor agonist
487:V-ATPase mechanism of action
475:domains of the enzyme. The V
2795:Tooltip γ-Aminobutyric acid
1069:Bafilomycin A1 product page
556:change amino acids in the V
324:produced from a variety of
4048:
2698:10.1016/j.phrs.2016.12.021
2515:10.1007/s11356-021-16427-4
2457:10.1186/s12985-023-01971-x
2318:Molecular Medicine Reports
2156:10.1016/j.phrs.2014.03.005
2106:10.1016/j.taap.2011.12.004
1991:10.1021/acschembio.1c00894
1934:10.1038/s41467-021-22111-5
1779:10.1016/j.tibs.2015.08.005
1659:The Journal of Antibiotics
942:Neurodegenerative diseases
917:The inflammatory myopathy
260:622.83 g/mol
3953:
3603:Glutamic acid (glutamate)
3569:Aspartic acid (aspartate)
3424:-CCG-III ((2S,3S,4R)-CCG)
3381:Glutamic acid (glutamate)
3363:Aspartic acid (aspartate)
3241:
3097:3-Hydrazinopropionic acid
2741:10.1016/j.lfs.2017.08.029
2191:10.1007/s00280-014-2637-z
782:oxidative phosphorylation
272:
225:
94:
48:
43:
34:
3923:3-Mercaptopropionic acid
3432:-Serine-O-sulphate (SOS)
3257:GABA receptor modulators
3043:3-Mercaptopropionic acid
2827:Tooltip GABA transporter
2686:Pharmacological Research
2271:Progress in Neurobiology
2144:Pharmacological Research
1409:10.1177/0748233709103405
1351:. Totowa, N.J.: Humana.
901:, the virus that causes
758:electrochemical gradient
643:Plasma membrane function
532:clathrin coated vesicles
3730:2-Amino-3-butenoic acid
3524:6-(4'-Phenylstyryl)-QDC
3408:-3-Hydroxyaspartic acid
1570:10.1074/jbc.M116.751255
1465:10.1073/pnas.85.21.7972
1010:. The lipophilic agent
919:Inclusion Body Myositis
855:Cryptococcus neoformans
811:reactive oxygen species
776:Bafilomycin acts as an
730:fluorescence microscopy
688:Inhibition of autophagy
351:vacuolar-type H -ATPase
346:damage and cell death.
3895:Methionine sulfoximine
3482:-3-Methylglutamic acid
1878:10.1074/jbc.M605532200
1829:10.1074/jbc.M404638200
1268:10.1074/jbc.M507727200
1224:10.1074/jbc.M003323200
1041:Matrix Metalloprotease
994:
744:Induction of apoptosis
716:
601:Intracellular function
561:bound to bafilomycin.
505:Adenosine triphosphate
465:Adenosine triphosphate
460:
443:
393:Caenorhabditis elegans
2331:10.3892/mmr.2014.2281
1914:Nature Communications
991:
877:Plasmodium falciparum
788:Research applications
710:
454:
441:
372:Discovery and history
322:macrolide antibiotics
3749:-Methylene-aspartate
2648:Autoimmunity Reviews
2564:10.1128/aac.00439-22
1979:ACS Chemical Biology
1553:"Streptomyces lohii"
961:Lysosomotropic drugs
862:in conjunction with
850:ATP-binding cassette
674:follicular lymphomas
379:Streptomyces griseus
4027:Isopropyl compounds
3862:Pyridoxal phosphate
3564:Chicago sky blue 6B
3529:6-Biphenyl-4-yl-QDC
2964:Chicago sky blue 6B
2838:4-Aminovaleric acid
2507:2022ESPR...2912336E
2098:2012ToxAP.259....1M
1926:2021NatCo..12.1782W
1871:(42): 31885–31893.
1822:(32): 33131–33138.
1671:10.1038/ja.2010.147
1515:10.1021/bi00066a008
1456:1988PNAS...85.7972B
1401:2009ToxIH..25..441S
1103:10.1242/jeb.200.1.1
726:electron microscopy
656:V-ATPase in disease
621:protein degradation
579:trans-golgi network
332:biological activity
31:
4002:Secondary alcohols
3885:2-Aminoadipic acid
3754:Hydrazinosuccinate
2501:(8): 12336–12346.
2395:Antiviral Research
2115:20.500.11794/15930
1728:10.1242/jeb.024067
995:
717:
612:receptor recycling
583:secretory vesicles
547:inhibitor of the V
461:
444:
384:cardiac glycosides
320:s are a family of
305:Infobox references
29:
4017:Conjugated dienes
4007:Tertiary alcohols
3979:
3978:
3949:
3948:
3935:
3669:
3668:
3587:
3584:Erythro-4-methyl-
3518:
3439:
3431:
3423:
3415:
3403:
3284:
3283:
3237:
3236:
3208:
3207:
3170:Valproate pivoxil
3134:
3107:γ-Acetylenic-GABA
3012:
3011:
2614:10.3390/v11060524
2242:10.4161/auto.6845
1628:10.4161/auto.2703
1563:(17): 7095–7104.
1509:(15): 3902–3906.
1450:(21): 7972–7976.
1347:Mayers D (2008).
1171:10.1002/cam4.1594
1031:Chemotherapeutics
956:drug interactions
913:Immunosuppressant
313:Chemical compound
311:
310:
16:(Redirected from
4039:
3933:
3916:
3912:
3878:
3874:
3810:
3806:
3794:Propargylglycine
3788:
3780:
3770:
3766:
3748:
3723:
3719:
3690:
3686:
3680:
3661:Xanthurenic acid
3585:
3554:Benzopurpurin 4B
3516:
3508:
3504:
3437:
3429:
3421:
3413:
3401:
3351:
3347:
3341:
3311:
3304:
3297:
3288:
3217:
3160:Sodium valproate
3132:
3087:
3083:
3055:
3033:
3029:
3023:
2944:
2940:
2828:
2824:
2818:
2796:
2792:
2783:
2776:
2769:
2760:
2753:
2752:
2724:
2718:
2717:
2681:
2672:
2671:
2643:
2637:
2636:
2626:
2616:
2592:
2586:
2585:
2575:
2543:
2537:
2536:
2526:
2486:
2480:
2479:
2469:
2459:
2444:Virology Journal
2435:
2429:
2428:
2418:
2385:
2379:
2378:
2350:
2344:
2343:
2333:
2309:
2303:
2302:
2266:
2255:
2254:
2244:
2220:
2211:
2210:
2174:
2168:
2167:
2139:
2128:
2127:
2117:
2080:
2067:
2066:
2028:
2019:
2018:
1970:
1964:
1963:
1953:
1905:
1899:
1898:
1880:
1856:
1850:
1849:
1831:
1807:
1801:
1800:
1790:
1758:
1741:
1740:
1730:
1706:
1693:
1692:
1682:
1650:
1641:
1640:
1630:
1606:
1593:
1592:
1582:
1572:
1548:
1535:
1534:
1494:
1488:
1487:
1477:
1467:
1435:
1429:
1428:
1384:
1371:
1370:
1344:
1333:
1332:
1322:
1311:10.1002/acn3.419
1290:
1281:
1280:
1270:
1246:
1237:
1236:
1226:
1202:
1193:
1192:
1182:
1165:(8): 3800–3811.
1150:
1115:
1114:
1086:
1075:
1066:
985:cultured cells.
793:Anti-tumorigenic
662:male infertility
650:Protein Kinase A
421:Streptomyces sp.
295:
289:
286:
285:
233:Chemical formula
218:
207:
196:
185:
174:
154:
134:
114:
39:
32:
21:
4047:
4046:
4042:
4041:
4040:
4038:
4037:
4036:
3982:
3981:
3980:
3975:
3945:
3914:
3904:
3876:
3866:
3847:Hexachlorophene
3808:
3798:
3786:
3778:
3768:
3758:
3746:
3721:
3711:
3688:
3665:
3628:Reactive blue 2
3506:
3496:
3349:
3330:
3315:
3285:
3280:
3267:
3233:
3204:
3150:Rosmarinic acid
3085:
3075:
3053:
3031:
3008:
2942:
2932:
2826:
2807:
2794:
2787:
2757:
2756:
2726:
2725:
2721:
2683:
2682:
2675:
2645:
2644:
2640:
2594:
2593:
2589:
2558:(7): e0043922.
2545:
2544:
2540:
2488:
2487:
2483:
2437:
2436:
2432:
2387:
2386:
2382:
2352:
2351:
2347:
2311:
2310:
2306:
2268:
2267:
2258:
2222:
2221:
2214:
2176:
2175:
2171:
2141:
2140:
2131:
2082:
2081:
2070:
2055:
2030:
2029:
2022:
1972:
1971:
1967:
1907:
1906:
1902:
1858:
1857:
1853:
1809:
1808:
1804:
1773:(10): 611–622.
1760:
1759:
1744:
1721:(Pt 3): 341–6.
1708:
1707:
1696:
1652:
1651:
1644:
1608:
1607:
1596:
1550:
1549:
1538:
1496:
1495:
1491:
1437:
1436:
1432:
1386:
1385:
1374:
1359:
1346:
1345:
1336:
1292:
1291:
1284:
1261:(44): 36841–7.
1248:
1247:
1240:
1217:(44): 34353–8.
1204:
1203:
1196:
1159:Cancer Medicine
1152:
1151:
1118:
1088:
1087:
1078:
1067:
1063:
1058:
1050:EGFR inhibitors
1033:
1024:
963:
958:
939:
915:
895:
882:red blood cells
872:
846:
795:
790:
774:
746:
690:
682:
680:Cellular action
670:drug resistance
658:
645:
603:
591:plasma membrane
575:
567:
559:
554:
550:
545:
541:
537:
529:
523:
510:
502:
494:
489:
482:
478:
474:
471:and cytosolic V
470:
449:
425:Streptomyces sp
389:
374:
314:
307:
302:
301:
300: ?)
291:
287:
283:
279:
249:
245:
241:
235:
221:
208:
177:
157:
137:
117:
104:
90:
30:Bafilomycin A1
23:
22:
15:
12:
11:
5:
4045:
4043:
4035:
4034:
4029:
4024:
4019:
4014:
4009:
4004:
3999:
3994:
3984:
3983:
3977:
3976:
3954:
3951:
3950:
3947:
3946:
3944:
3943:
3938:
3930:
3925:
3919:
3917:
3906:
3905:
3903:
3902:
3897:
3892:
3887:
3881:
3879:
3868:
3867:
3865:
3864:
3859:
3854:
3849:
3844:
3839:
3834:
3829:
3824:
3819:
3813:
3811:
3800:
3799:
3797:
3796:
3791:
3783:
3773:
3771:
3760:
3759:
3757:
3756:
3751:
3742:
3737:
3732:
3726:
3724:
3713:
3712:
3710:
3709:
3704:
3699:
3693:
3691:
3677:
3671:
3670:
3667:
3666:
3664:
3663:
3658:
3653:
3648:
3640:
3635:
3630:
3625:
3620:
3615:
3610:
3608:Kynurenic acid
3605:
3600:
3595:
3590:
3588:-glutamic acid
3581:
3579:Direct blue 71
3576:
3571:
3566:
3561:
3556:
3551:
3549:Bafilomycin A1
3546:
3541:
3536:
3531:
3526:
3521:
3511:
3509:
3498:
3497:
3495:
3494:
3489:
3484:
3476:
3471:
3466:
3461:
3456:
3451:
3446:
3434:
3426:
3418:
3410:
3398:
3393:
3388:
3383:
3378:
3373:
3365:
3360:
3354:
3352:
3338:
3332:
3331:
3316:
3314:
3313:
3306:
3299:
3291:
3282:
3281:
3279:
3278:
3271:
3265:
3260:
3253:
3246:
3242:
3239:
3238:
3235:
3234:
3232:
3231:
3225:
3223:
3221:Antivitamin B6
3214:
3210:
3209:
3206:
3205:
3203:
3202:
3193:
3192:
3187:
3182:
3177:
3172:
3167:
3162:
3157:
3147:
3142:
3137:
3129:
3124:
3119:
3114:
3109:
3104:
3099:
3090:
3088:
3077:
3076:
3074:
3073:
3064:
3063:
3058:
3050:
3045:
3036:
3034:
3020:
3014:
3013:
3010:
3009:
3007:
3006:
3001:
2996:
2994:Nipecotic acid
2991:
2986:
2984:N-Butyric acid
2981:
2976:
2971:
2966:
2961:
2959:Bafilomycin A1
2956:
2947:
2945:
2934:
2933:
2931:
2930:
2925:
2920:
2915:
2910:
2905:
2900:
2895:
2893:Nipecotic acid
2890:
2885:
2880:
2875:
2870:
2865:
2860:
2855:
2850:
2845:
2840:
2831:
2829:
2815:
2809:
2808:
2788:
2786:
2785:
2778:
2771:
2763:
2755:
2754:
2719:
2673:
2654:(8): 856–874.
2638:
2587:
2538:
2481:
2430:
2380:
2345:
2304:
2256:
2212:
2169:
2129:
2068:
2053:
2020:
1985:(3): 619–628.
1965:
1900:
1851:
1802:
1742:
1694:
1642:
1594:
1536:
1489:
1430:
1372:
1357:
1334:
1305:(6): 422–445.
1282:
1238:
1194:
1116:
1076:
1060:
1059:
1057:
1054:
1039:in decreasing
1032:
1029:
1023:
1020:
1012:xylometazoline
962:
959:
957:
951:
938:
935:
914:
911:
894:
891:
871:
870:Anti-parasitic
868:
845:
842:
794:
791:
789:
786:
773:
770:
745:
742:
698:autophagosomes
689:
686:
681:
678:
657:
654:
644:
641:
632:
631:
629:cell signaling
626:
623:
618:
613:
610:
602:
599:
574:
571:
565:
557:
552:
548:
543:
539:
535:
527:
522:
519:
508:
500:
492:
488:
485:
480:
476:
472:
468:
448:
445:
433:chiral centers
410:concanavalin-A
387:
373:
370:
359:P-type ATPases
327:Streptomycetes
312:
309:
308:
303:
281:
280:
276:standard state
273:
270:
269:
268:Yellow powder
266:
262:
261:
258:
252:
251:
247:
243:
239:
236:
231:
228:
227:
223:
222:
220:
219:
211:
209:
201:
198:
197:
187:
179:
178:
176:
175:
167:
165:
159:
158:
156:
155:
147:
145:
139:
138:
136:
135:
127:
125:
119:
118:
116:
115:
107:
105:
100:
97:
96:
92:
91:
52:
46:
45:
41:
40:
24:
18:Bafilomycin A1
14:
13:
10:
9:
6:
4:
3:
2:
4044:
4033:
4030:
4028:
4025:
4023:
4020:
4018:
4015:
4013:
4010:
4008:
4005:
4003:
4000:
3998:
3995:
3993:
3990:
3989:
3987:
3974:
3973:
3969:
3965:
3961:
3958:
3952:
3942:
3941:Semicarbazide
3939:
3937:
3936:-Allylglycine
3931:
3929:
3926:
3924:
3921:
3920:
3918:
3913:
3907:
3901:
3898:
3896:
3893:
3891:
3888:
3886:
3883:
3882:
3880:
3875:
3869:
3863:
3860:
3858:
3857:Palmitoyl-CoA
3855:
3853:
3852:Hydroxylamine
3850:
3848:
3845:
3843:
3840:
3838:
3835:
3833:
3830:
3828:
3825:
3823:
3820:
3818:
3815:
3814:
3812:
3807:
3801:
3795:
3792:
3790:
3784:
3782:
3775:
3774:
3772:
3767:
3761:
3755:
3752:
3750:
3743:
3741:
3738:
3736:
3733:
3731:
3728:
3727:
3725:
3720:
3714:
3708:
3705:
3703:
3700:
3698:
3695:
3694:
3692:
3687:
3681:
3678:
3676:
3672:
3662:
3659:
3657:
3654:
3652:
3649:
3647:
3645:
3641:
3639:
3636:
3634:
3631:
3629:
3626:
3624:
3621:
3619:
3616:
3614:
3611:
3609:
3606:
3604:
3601:
3599:
3596:
3594:
3591:
3589:
3582:
3580:
3577:
3575:
3572:
3570:
3567:
3565:
3562:
3560:
3557:
3555:
3552:
3550:
3547:
3545:
3542:
3540:
3537:
3535:
3532:
3530:
3527:
3525:
3522:
3520:
3513:
3512:
3510:
3505:
3499:
3493:
3490:
3488:
3485:
3483:
3481:
3477:
3475:
3472:
3470:
3467:
3465:
3462:
3460:
3457:
3455:
3454:Maslinic acid
3452:
3450:
3447:
3445:
3443:
3435:
3433:
3427:
3425:
3419:
3417:
3411:
3409:
3407:
3399:
3397:
3394:
3392:
3389:
3387:
3384:
3382:
3379:
3377:
3374:
3372:
3370:
3366:
3364:
3361:
3359:
3356:
3355:
3353:
3348:
3342:
3339:
3337:
3333:
3329:
3326:
3322:
3319:
3312:
3307:
3305:
3300:
3298:
3293:
3292:
3289:
3277:
3276:
3272:
3270:
3269:
3261:
3259:
3258:
3254:
3252:
3251:
3247:
3244:
3243:
3240:
3230:
3227:
3226:
3224:
3222:
3218:
3215:
3211:
3201:
3200:3-Methyl-GABA
3198:
3195:
3194:
3191:
3188:
3186:
3183:
3181:
3180:Valproic acid
3178:
3176:
3173:
3171:
3168:
3166:
3163:
3161:
3158:
3155:
3151:
3148:
3146:
3143:
3141:
3138:
3136:
3130:
3128:
3125:
3123:
3120:
3118:
3115:
3113:
3110:
3108:
3105:
3103:
3100:
3098:
3095:
3092:
3091:
3089:
3084:
3078:
3072:
3071:3-Methyl-GABA
3069:
3066:
3065:
3062:
3061:Semicarbazide
3059:
3057:
3056:-Allylglycine
3051:
3049:
3046:
3044:
3041:
3038:
3037:
3035:
3030:
3024:
3021:
3019:
3015:
3005:
3002:
3000:
2997:
2995:
2992:
2990:
2987:
2985:
2982:
2980:
2977:
2975:
2972:
2970:
2967:
2965:
2962:
2960:
2957:
2955:
2952:
2949:
2948:
2946:
2941:
2935:
2929:
2926:
2924:
2921:
2919:
2916:
2914:
2911:
2909:
2906:
2904:
2901:
2899:
2896:
2894:
2891:
2889:
2886:
2884:
2883:Ibotenic acid
2881:
2879:
2876:
2874:
2871:
2869:
2866:
2864:
2861:
2859:
2856:
2854:
2851:
2849:
2846:
2844:
2841:
2839:
2836:
2833:
2832:
2830:
2825:
2819:
2816:
2814:
2810:
2806:
2803:
2799:
2793:
2784:
2779:
2777:
2772:
2770:
2765:
2764:
2761:
2750:
2746:
2742:
2738:
2734:
2730:
2729:Life Sciences
2723:
2720:
2715:
2711:
2707:
2703:
2699:
2695:
2691:
2687:
2680:
2678:
2674:
2669:
2665:
2661:
2657:
2653:
2649:
2642:
2639:
2634:
2630:
2625:
2620:
2615:
2610:
2606:
2602:
2598:
2591:
2588:
2583:
2579:
2574:
2569:
2565:
2561:
2557:
2553:
2549:
2542:
2539:
2534:
2530:
2525:
2520:
2516:
2512:
2508:
2504:
2500:
2496:
2492:
2485:
2482:
2477:
2473:
2468:
2463:
2458:
2453:
2449:
2445:
2441:
2434:
2431:
2426:
2422:
2417:
2412:
2408:
2404:
2400:
2396:
2392:
2384:
2381:
2376:
2372:
2368:
2364:
2361:(4): 349–53.
2360:
2356:
2349:
2346:
2341:
2337:
2332:
2327:
2324:(2): 1103–7.
2323:
2319:
2315:
2308:
2305:
2300:
2296:
2292:
2288:
2284:
2280:
2276:
2272:
2265:
2263:
2261:
2257:
2252:
2248:
2243:
2238:
2235:(7): 849–50.
2234:
2230:
2226:
2219:
2217:
2213:
2208:
2204:
2200:
2196:
2192:
2188:
2185:(3): 439–47.
2184:
2180:
2173:
2170:
2165:
2161:
2157:
2153:
2149:
2145:
2138:
2136:
2134:
2130:
2125:
2121:
2116:
2111:
2107:
2103:
2099:
2095:
2091:
2087:
2079:
2077:
2075:
2073:
2069:
2064:
2060:
2056:
2054:9780123646309
2050:
2046:
2042:
2038:
2034:
2027:
2025:
2021:
2016:
2012:
2008:
2004:
2000:
1996:
1992:
1988:
1984:
1980:
1976:
1969:
1966:
1961:
1957:
1952:
1947:
1943:
1939:
1935:
1931:
1927:
1923:
1919:
1915:
1911:
1904:
1901:
1896:
1892:
1888:
1884:
1879:
1874:
1870:
1866:
1862:
1855:
1852:
1847:
1843:
1839:
1835:
1830:
1825:
1821:
1817:
1813:
1806:
1803:
1798:
1794:
1789:
1784:
1780:
1776:
1772:
1768:
1764:
1757:
1755:
1753:
1751:
1749:
1747:
1743:
1738:
1734:
1729:
1724:
1720:
1716:
1712:
1705:
1703:
1701:
1699:
1695:
1690:
1686:
1681:
1676:
1672:
1668:
1665:(1): 159–62.
1664:
1660:
1656:
1649:
1647:
1643:
1638:
1634:
1629:
1624:
1621:(3): 228–30.
1620:
1616:
1612:
1605:
1603:
1601:
1599:
1595:
1590:
1586:
1581:
1576:
1571:
1566:
1562:
1558:
1554:
1547:
1545:
1543:
1541:
1537:
1532:
1528:
1524:
1520:
1516:
1512:
1508:
1504:
1500:
1493:
1490:
1485:
1481:
1476:
1471:
1466:
1461:
1457:
1453:
1449:
1445:
1441:
1434:
1431:
1426:
1422:
1418:
1414:
1410:
1406:
1402:
1398:
1394:
1390:
1383:
1381:
1379:
1377:
1373:
1368:
1364:
1360:
1358:9781603275958
1354:
1350:
1343:
1341:
1339:
1335:
1330:
1326:
1321:
1316:
1312:
1308:
1304:
1300:
1296:
1289:
1287:
1283:
1278:
1274:
1269:
1264:
1260:
1256:
1252:
1245:
1243:
1239:
1234:
1230:
1225:
1220:
1216:
1212:
1208:
1201:
1199:
1195:
1190:
1186:
1181:
1176:
1172:
1168:
1164:
1160:
1156:
1149:
1147:
1145:
1143:
1141:
1139:
1137:
1135:
1133:
1131:
1129:
1127:
1125:
1123:
1121:
1117:
1112:
1108:
1104:
1100:
1097:(Pt 1): 1–8.
1096:
1092:
1085:
1083:
1081:
1077:
1074:
1070:
1065:
1062:
1055:
1053:
1051:
1046:
1042:
1038:
1030:
1028:
1021:
1019:
1017:
1013:
1009:
1003:
1001:
990:
986:
984:
980:
979:vacuolization
976:
972:
968:
960:
955:
952:
950:
946:
943:
936:
934:
932:
927:
922:
920:
912:
910:
908:
904:
900:
892:
890:
887:
886:P. falciparum
883:
879:
878:
869:
867:
865:
861:
860:C. neoformans
857:
856:
851:
843:
841:
839:
835:
829:
827:
823:
819:
815:
812:
806:
804:
800:
792:
787:
785:
783:
779:
771:
769:
767:
763:
759:
755:
751:
743:
741:
739:
734:
731:
727:
721:
714:
709:
705:
703:
699:
695:
687:
685:
679:
677:
675:
671:
667:
666:osteopetrosis
663:
655:
653:
651:
642:
640:
638:
630:
627:
624:
622:
619:
617:
614:
611:
608:
607:
606:
600:
598:
596:
592:
588:
584:
580:
572:
570:
562:
533:
520:
518:
515:
506:
498:
497:glutamic acid
486:
484:
466:
458:
453:
446:
440:
436:
434:
428:
426:
422:
418:
413:
411:
407:
403:
399:
395:
394:
385:
381:
380:
371:
369:
367:
362:
360:
356:
352:
347:
345:
344:mitochondrial
341:
337:
333:
329:
328:
323:
319:
306:
299:
294:
277:
271:
267:
264:
263:
259:
257:
254:
253:
237:
234:
230:
229:
224:
217:
213:
212:
210:
204:
200:
199:
195:
191:
188:
186:
184:ECHA InfoCard
181:
180:
173:
169:
168:
166:
164:
161:
160:
153:
149:
148:
146:
144:
141:
140:
133:
129:
128:
126:
124:
121:
120:
113:
109:
108:
106:
103:
99:
98:
93:
88:
84:
80:
76:
72:
68:
64:
60:
56:
51:
47:
42:
38:
33:
27:
19:
3956:
3955:
3789:-Cycloserine
3643:
3539:Acid red 114
3515:4-Methylene-
3479:
3441:
3405:
3368:
3273:
3262:
3255:
3248:
3196:
3165:Valnoctamide
3135:-Cycloserine
3093:
3067:
3039:
2950:
2834:
2732:
2728:
2722:
2689:
2685:
2651:
2647:
2641:
2604:
2600:
2590:
2555:
2551:
2541:
2498:
2494:
2484:
2447:
2443:
2433:
2398:
2394:
2383:
2358:
2354:
2348:
2321:
2317:
2307:
2274:
2270:
2232:
2228:
2182:
2178:
2172:
2147:
2143:
2089:
2085:
2036:
2032:
1982:
1978:
1968:
1917:
1913:
1903:
1868:
1864:
1854:
1819:
1815:
1805:
1770:
1766:
1718:
1714:
1662:
1658:
1618:
1614:
1560:
1556:
1506:
1503:Biochemistry
1502:
1492:
1447:
1443:
1433:
1395:(7): 441–6.
1392:
1388:
1348:
1302:
1298:
1258:
1254:
1214:
1210:
1162:
1158:
1094:
1090:
1064:
1034:
1025:
1004:
999:
996:
982:
975:ion trapping
964:
953:
947:
940:
931:plasmablasts
923:
916:
896:
885:
875:
873:
859:
853:
847:
830:
817:
816:
807:
802:
796:
775:
766:osteosarcoma
762:cytochrome c
747:
735:
722:
718:
713:autolysosome
691:
683:
659:
646:
633:
604:
576:
563:
524:
490:
462:
456:
429:
424:
420:
416:
414:
405:
402:synaptosomes
391:
377:
375:
365:
363:
348:
325:
317:
315:
132:ChEMBL290814
95:Identifiers
86:
82:
78:
74:
70:
66:
62:
58:
54:
26:
3992:Antibiotics
3827:Chloroquine
3656:Valinomycin
3651:Trypan blue
3633:Rose bengal
3618:NPPB (N144)
3492:WAY-213,613
3396:Kainic acid
3358:Amphetamine
3336:Transporter
3229:Ginkgotoxin
3197:Activators:
3094:Inhibitors:
3068:Activators:
3040:Inhibitors:
2999:Valinomycin
2951:Inhibitors:
2898:NNC 05-2090
2835:Inhibitors:
2813:Transporter
2692:: 177–184.
2092:(1): 1–12.
2039:: 259–319.
1920:(1): 1782.
1022:Chloroquine
967:chloroquine
864:calcineurin
844:Anti-fungal
838:synergistic
772:K transport
616:endocytosis
595:osteoclasts
457:Attribution
400:) from rat
318:bafilomycin
265:Appearance
226:Properties
190:100.150.187
4022:Macrolides
3986:Categories
3890:JFD01307SC
3623:Ponceau SS
3598:Furosemide
3593:Evans blue
3559:Bumetamide
3519:-glutamate
3328:modulators
3321:metabolism
3190:Vigabatrin
3185:Valpromide
3154:lemon balm
3140:Phenelzine
3122:Gabaculine
3004:Vigabatrin
2969:Evans blue
2913:SKF-89976A
2873:Gabaculine
2848:Arecaidine
2805:modulators
2798:metabolism
2607:(6): 524.
2401:: 105484.
1056:References
971:sertraline
907:Zika virus
899:SARS-CoV-2
893:Anti-viral
799:metastasis
750:PC12 cells
702:cathepsins
417:S. griseus
406:S. griseus
340:ionophores
256:Molar mass
143:ChemSpider
112:88899-55-2
102:CAS Number
50:IUPAC name
3957:See also:
3822:Bithionol
3777:β-Chloro-
3613:Nigericin
3325:transport
3318:Glutamate
3127:Isoniazid
2989:Nigericin
2954:β-Alanine
2928:Tiagabine
2918:SNAP-5114
2843:β-Alanine
2802:transport
2735:: 53–67.
2714:207368923
2450:(1): 18.
2277:: 64–85.
2229:Autophagy
2015:246775779
1999:1554-8937
1942:2041-1723
1887:0021-9258
1838:0021-9258
1615:Autophagy
1523:0006-2960
1367:437345683
1073:Fermentek
1045:cisplatin
993:lysosome.
834:cisplatin
826:sorafenib
822:xenograft
778:ionophore
754:apoptosis
694:Autophagy
625:autophagy
587:endosomes
336:autophagy
4012:Lactones
3781:-alanine
3487:UCPH-101
3474:Theanine
3469:TFB-TBOA
3459:SYM-2081
3444:-2,4-PDC
3245:See also
2908:Riluzole
2888:Muscimol
2878:Guvacine
2749:28866100
2706:28025106
2668:28572049
2633:31174294
2582:35703551
2533:34562220
2476:36721152
2425:36503013
2375:10972492
2340:24890793
2291:28385648
2251:18758232
2207:24642257
2199:25422156
2164:24657238
2124:22198553
2063:12921239
2007:35148071
1960:33741963
1895:16912037
1846:15180988
1797:26410601
1737:19151208
1689:21102599
1637:16874105
1589:28292933
1425:30966042
1417:19736254
1329:28589170
1277:16135514
1233:10915784
1189:29926527
1000:in vitro
983:in vitro
981:seen in
954:In vitro
903:COVID-19
803:in vitro
514:arginine
366:in vitro
355:lysosome
163:DrugBank
152:10251049
3997:Polyols
2979:Glycine
2868:EF-1502
2624:6630673
2601:Viruses
2573:9295568
2524:8475441
2503:Bibcode
2467:9887234
2416:9729583
2299:3811723
2150:: 1–8.
2094:Bibcode
1951:7979754
1922:Bibcode
1788:4589219
1680:5592157
1580:5409476
1531:8385991
1484:2973058
1452:Bibcode
1397:Bibcode
1320:5454400
1180:6089187
1111:9023991
818:In vivo
738:neurons
652:(PKA).
298:what is
296: (
250:
216:6436223
203:PubChem
172:DB06733
4032:Enones
3842:GW5074
3702:CB-839
3675:Enzyme
3503:vGluTs
3082:GABA-T
3018:Enzyme
2903:NO-711
2853:CI-966
2747:
2712:
2704:
2666:
2631:
2621:
2580:
2570:
2531:
2521:
2474:
2464:
2423:
2413:
2373:
2338:
2297:
2289:
2249:
2205:
2197:
2162:
2122:
2061:
2051:
2013:
2005:
1997:
1958:
1948:
1940:
1893:
1885:
1844:
1836:
1795:
1785:
1735:
1687:
1677:
1635:
1587:
1577:
1529:
1521:
1482:
1475:282335
1472:
1423:
1415:
1365:
1355:
1327:
1317:
1275:
1231:
1187:
1177:
1109:
836:had a
447:Target
293:verify
290:
123:ChEMBL
44:Names
3697:BPTES
3646:-ACDP
3644:trans
3534:7-CKA
3480:threo
3442:trans
3406:threo
3404:-(-)-
3391:HIP-B
3386:HIP-A
3371:-ACBD
3346:EAATs
3213:Other
2939:VIAAT
2710:S2CID
2295:S2CID
2203:S2CID
2011:S2CID
1421:S2CID
1071:from
1037:taxol
1014:, an
1008:aorta
926:Lupus
637:Notch
3928:AAOA
3832:EGCG
3817:AAOA
3735:AAOA
3638:SITS
3574:DIDS
3464:TBOA
3449:MPDC
3416:-αAA
3376:DHKA
3323:and
3264:GABA
3112:AOAA
3102:DABA
3048:AAOA
2974:GABA
2923:TACA
2858:DABA
2800:and
2791:GABA
2745:PMID
2702:PMID
2664:PMID
2629:PMID
2578:PMID
2529:PMID
2472:PMID
2421:PMID
2371:PMID
2336:PMID
2287:PMID
2247:PMID
2195:PMID
2160:PMID
2120:PMID
2059:PMID
2049:ISBN
2003:PMID
1995:ISSN
1956:PMID
1938:ISSN
1891:PMID
1883:ISSN
1842:PMID
1834:ISSN
1793:PMID
1733:PMID
1685:PMID
1633:PMID
1585:PMID
1527:PMID
1519:ISSN
1480:PMID
1413:PMID
1363:OCLC
1353:ISBN
1325:PMID
1273:PMID
1229:PMID
1185:PMID
1107:PMID
969:and
585:and
398:GABA
316:The
3911:GAD
3837:GTP
3805:GDH
3765:ALT
3740:AMB
3718:AST
3707:DON
3685:GAH
3369:cis
3145:PEH
3117:EOS
3028:GAD
2823:GAT
2737:doi
2733:188
2694:doi
2690:117
2656:doi
2619:PMC
2609:doi
2568:PMC
2560:doi
2519:PMC
2511:doi
2462:PMC
2452:doi
2411:PMC
2403:doi
2399:209
2363:doi
2326:doi
2279:doi
2275:153
2237:doi
2187:doi
2152:doi
2110:hdl
2102:doi
2090:259
2041:doi
2037:226
1987:doi
1946:PMC
1930:doi
1873:doi
1869:281
1824:doi
1820:279
1783:PMC
1775:doi
1723:doi
1719:212
1675:PMC
1667:doi
1623:doi
1575:PMC
1565:doi
1561:292
1511:doi
1470:PMC
1460:doi
1405:doi
1315:PMC
1307:doi
1263:doi
1259:280
1219:doi
1215:275
1175:PMC
1167:doi
1099:doi
1095:200
924:In
748:In
736:In
206:CID
85:,16
81:,15
77:,13
73:,11
3988::
3970:•
3966:•
3962:•
3873:GS
3747:DL
3745:β-
2743:.
2731:.
2708:.
2700:.
2688:.
2676:^
2662:.
2652:16
2650:.
2627:.
2617:.
2605:11
2603:.
2599:.
2576:.
2566:.
2556:66
2554:.
2550:.
2527:.
2517:.
2509:.
2499:29
2497:.
2493:.
2470:.
2460:.
2448:20
2446:.
2442:.
2419:.
2409:.
2397:.
2393:.
2369:.
2357:.
2334:.
2322:10
2320:.
2316:.
2293:.
2285:.
2273:.
2259:^
2245:.
2231:.
2227:.
2215:^
2201:.
2193:.
2183:75
2181:.
2158:.
2148:82
2146:.
2132:^
2118:.
2108:.
2100:.
2088:.
2071:^
2057:.
2047:.
2035:.
2023:^
2009:.
2001:.
1993:.
1983:17
1981:.
1977:.
1954:.
1944:.
1936:.
1928:.
1918:12
1916:.
1912:.
1889:.
1881:.
1867:.
1863:.
1840:.
1832:.
1818:.
1814:.
1791:.
1781:.
1771:40
1769:.
1765:.
1745:^
1731:.
1717:.
1713:.
1697:^
1683:.
1673:.
1663:64
1661:.
1657:.
1645:^
1631:.
1617:.
1613:.
1597:^
1583:.
1573:.
1559:.
1555:.
1539:^
1525:.
1517:.
1507:32
1505:.
1501:.
1478:.
1468:.
1458:.
1448:85
1446:.
1442:.
1419:.
1411:.
1403:.
1393:25
1391:.
1375:^
1361:.
1337:^
1323:.
1313:.
1301:.
1297:.
1285:^
1271:.
1257:.
1253:.
1241:^
1227:.
1213:.
1209:.
1197:^
1183:.
1173:.
1161:.
1157:.
1119:^
1105:.
1093:.
1079:^
909:.
884:,
676:.
664:,
639:.
427:.
244:58
240:35
69:,9
65:,8
61:,7
57:,5
53:(3
3934:L
3787:L
3779:L
3586:L
3517:L
3440:-
3438:L
3430:L
3422:L
3414:L
3402:L
3310:e
3303:t
3296:v
3266:A
3156:)
3152:(
3133:L
3054:L
2782:e
2775:t
2768:v
2751:.
2739::
2716:.
2696::
2670:.
2658::
2635:.
2611::
2584:.
2562::
2535:.
2513::
2505::
2478:.
2454::
2427:.
2405::
2377:.
2365::
2359:3
2342:.
2328::
2301:.
2281::
2253:.
2239::
2233:4
2209:.
2189::
2166:.
2154::
2126:.
2112::
2104::
2096::
2065:.
2043::
2017:.
1989::
1962:.
1932::
1924::
1897:.
1875::
1848:.
1826::
1799:.
1777::
1739:.
1725::
1691:.
1669::
1639:.
1625::
1619:2
1591:.
1567::
1533:.
1513::
1486:.
1462::
1454::
1427:.
1407::
1399::
1369:.
1331:.
1309::
1303:4
1279:.
1265::
1235:.
1221::
1191:.
1169::
1163:7
1113:.
1101::
566:o
558:o
553:o
549:o
544:o
540:o
536:o
528:o
526:V
509:1
501:o
493:o
481:o
477:1
473:1
469:o
388:i
288:N
248:9
246:O
242:H
238:C
87:R
83:S
79:E
75:E
71:S
67:S
63:R
59:E
55:Z
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.